Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

Unitat de Recerca en Malalties Hepatobiliars

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Antonio González Fernández, Lluis Castells Fusté, Silvia Sauleda Oliveras, Lluís Palenzuela Díaz, Maria Buti Ferret, Josep Quer Sivila, Unitat de Recerca en Malalties Hepatobiliars, Juan Ignacio Esteban Mur, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 383
Duration: 01/01/2010 - 30/04/2014

La inhibició de la transmissió adrenèrgica contribueix a la vasodilatació esplàcnica de la hipertensió portal

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 36000
Reference: POST-MIR/CAIX/02/07
Duration: 01/07/2007 - 30/06/2009

CIBER Enfermedades hepáticas y digestivas (CIBEREHD)

IP: Joan Genescà Ferrer
Collaborators: Lluís Palenzuela Díaz, Nuria Raguer Sanz
Funding agency: CIBER Enfermedades Hepáticas y Digestivas
Funding:
Reference: CB06/04/0007
Duration: 01/01/2007 - 31/12/2010

Utilidad de la PCR bacteriana en el diagnostico de la peritonitis bacteriana espontánea del cirrotico.

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 15205.61
Reference: 01/1390
Duration: 17/07/2001 - 31/12/2002

Related news

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Related professionals

Estela Garcia Gea

Estela Garcia Gea

Research technician
Psychiatry, Mental Health and Addictions
Read more
Rucsanda Pinteac

Rucsanda Pinteac

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Santiago Ramon y Cajal Agüeras

Santiago Ramon y Cajal Agüeras

Head of group
Translational Molecular Pathology
Read more
Carlos Mauricio Larrarte King

Carlos Mauricio Larrarte King

Research technician
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.